Skip to content
OUR HISTORY

Celebrating a legacy of innovation and industry firsts, from developing bespoke medical kits to founding the first global response center for aviation. We're committed to pioneering solutions and delivering excellence for every journey.

Women in pain due to UTI, laying in bed

Case Study | UTI NOT RESPONDING TO ANTIBIOTICS AT SEA

Case Study | UTI NOT RESPONDING TO ANTIBIOTICS AT SEA
1:41

When a UTI does not respond to antibiotics and diagnostic capability is limited, escalation may be necessary.

In this case, delayed effective treatment and remote operating conditions resulted in medical evacuation for definitive diagnosis and care. 

THE CASE

Region:
Solomon Islands (South Pacific)

Crewmember Profile:
Female deckhand, late 20s, with a suspected history of recurrent urinary tract infections

Incident:
Persistent urinary tract infection (UTI) symptoms unresponsive to initial onboard antibiotic treatment, later requiring medical evacuation

MedAire Services Used:
MedAire telemedical support
Medical evacuation coordination
Global provider network

What Happened?

A crewmember developed symptoms consistent with a urinary tract infection while operating in a remote cruising region in the Solomon Islands.

Initial treatment was started onboard using antibiotics available in the yacht’s medical kit. However, symptoms persisted and progressively worsened across two treatment cycles.

Without access to urine culture and sensitivity testing, the causative organism and antibiotic resistance profile could not be identified. This prevented targeted treatment.

Given the vessel’s remote location and limited local diagnostic capability, the case required escalation to protect crew health and ensure appropriate care.

 

MEDAIRE'S RESPONSE

  • Clinical assessment. MedAire supported the vessel remotely, assessing the crewmember’s symptoms, treatment history, and clinical risk.
  • Evaluation of treatment response. The lack of improvement suggested possible antibiotic resistance or an alternative diagnosis..
  • Consideration of diagnostic limitations. The absence of urine culture and sensitivity testing limited the ability to provide targeted treatment onboard.
  • Assessment of local medical capability. The medical team evaluated local healthcare infrastructure and the potential limitations for further investigation and follow-up care.

 


  • Decision to escalate care. Given the clinical picture and operational context, the crewmember was evacuated for advanced assessment and treatment.
  • Medical evacuation coordination. The crewmember was transported commercially from the Solomon Islands to Sydney, and then onward to Brisbane.
  • Access to advanced care. Upon arrival, she was treated within MedAire’s global provider network, where advanced diagnostics and specialist care were available.

OUTCOME

Further testing confirmed that the causative organism was resistant to the antibiotics initially taken that were available onboard.

With appropriate, targeted treatment, the crewmember’s condition improved.

However, the delay in effective treatment based on sensitivities resulted in prolonged discomfort and required a full medical evacuation that may have been avoidable with earlier diagnostic insight and targeted therapies.


KEY LEARNING POINTS

  • Persistent or recurring symptoms require reassessment
    A lack of improvement following initial treatment should prompt early escalation and medical consultation.
  • Antibiotic resistance can impact outcomes
    Common UTI antibiotics may not be effective for all individuals, particularly in recurrent cases where resistance profiles can vary, highlighting the importance of assessing when onboard medical kits are appropriate versus when shoreside medical care is required.
  • Local Medical Expertise: Understanding regional healthcare capabilities is critical. In this case, MedAire’s experience in the specific location in Solomon Islands informed the decision to escalate care and proceed with evacuation due to the local limitations and risks that could further impact recovery.
  • Early diagnosis: Where feasible, urine culture and sensitivity testing can support more targeted treatment and reduce escalation.
  • Proactive planning: For crew with a history of recurrent UTIs, having prior culture results and known antibiotic sensitivities can help inform medical kit planning and ensure more appropriate treatment is available onboard. Crew members with known recurrent UTIs should proactively seek GP review during active infections to obtain urine cultures, as these provide valuable evidence for recurrent infections within a timeframe. Crew members should have these to hand while onboard.

BEST PRACTICES TO MINIMIZE UTIs RISK ONBOARD

  • Maintain adequate hydration
  • Avoid delaying urination
  • Ensure good personal hygiene practices
  • Urinate after sexual activity
  • Avoid irritants such as perfumed hygiene products
  • Wear breathable cotton clothing where possible